Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II

Research output: Contribution to journalArticle

60 Scopus citations

Fingerprint Dive into the research topics of 'Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II'. Together they form a unique fingerprint.

Medicine & Life Sciences